Published in Clin Infect Dis on September 21, 2007
The human nasal microbiota and Staphylococcus aureus carriage. PLoS One (2010) 2.50
Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis (2009) 2.41
Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection. Nat Immunol (2013) 2.22
Neutrophils in innate host defense against Staphylococcus aureus infections. Semin Immunopathol (2011) 2.17
Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin North Am (2009) 2.01
Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections. Clin Orthop Relat Res (2013) 1.53
Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia. Medicine (Baltimore) (2009) 1.16
Lifestyle-Associated Risk Factors for Community-Acquired Methicillin-Resistant Staphylococcus aureus Carriage in the Netherlands: An Exploratory Hospital-Based Case-Control Study. PLoS One (2013) 1.13
Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection. PLoS One (2009) 1.11
Predictive ability of positive clinical culture results and International Classification of Diseases, Ninth Revision, to identify and classify noninvasive Staphylococcus aureus infections: a validation study. Infect Control Hosp Epidemiol (2010) 1.03
Decline of meticillin-resistant Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensification. BMJ Open (2011) 1.02
Lack of a major role of Staphylococcus aureus Panton-Valentine leukocidin in lower respiratory tract infection in nonhuman primates. Am J Pathol (2010) 1.01
Transmission of methicillin-resistant Staphylococcus aureus CC398 from livestock veterinarians to their household members. PLoS One (2014) 0.98
Comparison of two PCR-based methods and conventional culture for the detection of nasal carriage of Staphylococcus aureus in pre-operative patients. Eur J Clin Microbiol Infect Dis (2009) 0.96
The Staphylococcus aureus alpha-toxin perturbs the barrier function in Caco-2 epithelial cell monolayers by altering junctional integrity. Infect Immun (2012) 0.96
The psmα locus regulates production of Staphylococcus aureus alpha-toxin during infection. Infect Immun (2014) 0.96
Comprehensive characterization of methicillin-resistant Staphylococcus aureus subsp. aureus COL secretome by two-dimensional liquid chromatography and mass spectrometry. Mol Cell Proteomics (2010) 0.95
Polymer-Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications. Adv Funct Mater (2012) 0.94
Cost-effectiveness of preoperative screening and eradication of Staphylococcus aureus carriage. PLoS One (2011) 0.93
Serologic assay to quantify human immunoglobulin G antibodies to the Staphylococcus aureus iron surface determinant B antigen. Clin Vaccine Immunol (2009) 0.88
Trends in postoperative sepsis: are we improving outcomes? Surg Infect (Larchmt) (2009) 0.87
Staphylococcus aureus hyaluronidase is a CodY-regulated virulence factor. Infect Immun (2014) 0.87
Covering all the Bases: Preclinical Development of an Effective Staphylococcus aureus Vaccine. Front Immunol (2014) 0.87
Cost-effectiveness and efficacy of spa, SCCmec, and PVL genotyping of methicillin-resistant Staphylococcus aureus as compared to pulsed-field gel Electrophoresis. PLoS One (2013) 0.86
Modeling and predicting drug resistance rate and strength. Eur J Clin Microbiol Infect Dis (2016) 0.84
Nasal screening for MRSA: different swabs--different results! PLoS One (2014) 0.81
Vaccination with a UV-irradiated genetically attenuated mutant of Staphylococcus aureus provides protection against subsequent systemic infection. J Infect Dis (2012) 0.81
Bacillithiol has a role in Fe-S cluster biogenesis in Staphylococcus aureus. Mol Microbiol (2015) 0.81
First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia. J Clin Microbiol (2010) 0.80
The burden of nosocomial staphylococcus aureus bloodstream infection in South Korea: a prospective hospital-based nationwide study. BMC Infect Dis (2014) 0.80
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models. Antimicrob Agents Chemother (2009) 0.79
Prevention and treatment of Staphylococcus aureus biofilms. Expert Rev Anti Infect Ther (2015) 0.79
Aspects of eukaryotic-like signaling in Gram-positive cocci: a focus on virulence. Future Microbiol (2011) 0.79
Human-associated methicillin-resistant Staphylococcus aureus from a subtropical recreational marine beach. Microb Ecol (2013) 0.78
Kinase Inhibitors that Increase the Sensitivity of Methicillin Resistant Staphylococcus aureus to β-Lactam Antibiotics. Pathogens (2015) 0.77
Prophylactic intrawound application of vancomycin powder in instrumented spinal fusion surgery. Korean J Spine (2013) 0.77
Clinical evaluation of Bio-Rad MRSASelect™ medium for the detection of livestock-associated methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (2010) 0.77
Performance of SaSelect, a chromogenic medium for detection of staphylococci in clinical specimens. J Clin Microbiol (2014) 0.76
Methamphetamine Alters the Antimicrobial Efficacy of Phagocytic Cells during Methicillin-Resistant Staphylococcus aureus Skin Infection. MBio (2015) 0.76
Performance of Oxoid Brilliance MRSA medium for detection of methicillin-resistant Staphylococcus aureus: an in vitro study. Eur J Clin Microbiol Infect Dis (2009) 0.75
Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus Infection. MBio (2016) 0.75
Exaggerated Acute Lung Injury and Impaired Antibacterial Defenses During Staphylococcus aureus Infection in Rats with the Metabolic Syndrome. PLoS One (2015) 0.75
Increasing Incidence, Cost, and Seasonality in Patients Hospitalized for Cellulitis. Open Forum Infect Dis (2017) 0.75
IL-17A plays an important role in protection induced by vaccination with fibronectin-binding domain of fibronectin-binding protein A against Staphylococcus aureus infection. Med Microbiol Immunol (2017) 0.75
The burden of selected digestive diseases in the United States. Gastroenterology (2002) 6.79
Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis (2007) 4.69
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin Infect Dis (2004) 4.29
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet (2004) 3.92
Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, The Netherlands. Emerg Infect Dis (2011) 3.37
The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol (2006) 3.30
Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women. JAMA (2003) 2.97
Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev (2008) 2.69
Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother (2007) 2.42
Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis (2009) 2.39
Clinical experience with linezolid for the treatment of nocardia infection. Clin Infect Dis (2003) 2.37
The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch Intern Med (2005) 2.33
Interpretation of antibiotic concentration ratios measured in epithelial lining fluid. Antimicrob Agents Chemother (2007) 2.05
Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis (2003) 2.02
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents (2008) 1.92
Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS). Am J Kidney Dis (2013) 1.79
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme. Clin Pharmacokinet (2003) 1.70
Incremental direct expenditure of treating asthma in the United States. J Asthma (2009) 1.68
Barriers to expanding primary care roles for chiropractors: The role of chiropractic as primary care gatekeeper. J Manipulative Physiol Ther (2002) 1.67
Performance of CHROMagar MRSA medium for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2005) 1.54
Loss of the mecA gene during storage of methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol (2005) 1.49
Population pharmacokinetics of linezolid in patients treated in a compassionate-use program. Antimicrob Agents Chemother (2003) 1.49
Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes (2009) 1.48
Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia. J Am Geriatr Soc (2007) 1.38
Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit. Antimicrob Agents Chemother (2013) 1.29
Bone density-related predictors of blood lead level among peri- and postmenopausal women in the United States: The Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol (2004) 1.28
Novel pharmacokinetic-pharmacodynamic model for prediction of outcomes with an extended-release formulation of ciprofloxacin. Antimicrob Agents Chemother (2004) 1.25
Analysis of prophages harbored by the human-adapted subpopulation of Staphylococcus aureus CC398. Infect Genet Evol (2013) 1.23
High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in The Netherlands. J Clin Microbiol (2003) 1.19
The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin. J Antimicrob Chemother (2002) 1.18
A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes. Clin Ther (2002) 1.14
Recent emergence of Staphylococcus aureus clonal complex 398 in human blood cultures. PLoS One (2012) 1.12
Reduction of surgical site infections after implementation of a bundle of care. PLoS One (2012) 1.09
Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother (2007) 1.09
Outbreak of methicillin-resistant Staphylococcus aureus ST398 in a Dutch nursing home. Infect Control Hosp Epidemiol (2012) 1.09
The economic impact of infection control: making the business case for increased infection control resources. Am J Infect Control (2005) 1.08
Highly resistant microorganisms in a teaching hospital: the role of horizontal spread in a setting of endemicity. Infect Control Hosp Epidemiol (2008) 1.07
Clinical evaluation of Oxoid Brilliance MRSA Agar in comparison with bioMerieux MRSA ID medium for detection of livestock-associated meticillin-resistant Staphylococcus aureus. J Med Microbiol (2011) 1.04
Two clones of methicillin-resistant Staphylococcus aureus in Poland. Clin Microbiol Infect (1997) 0.99
Prevalence and correlates of potentially inappropriate prescribing among ambulatory older patients in the year 2001: comparison of three explicit criteria. Clin Ther (2005) 0.97
Dynamics and determinants of Staphylococcus aureus carriage in livestock veterinarians: a prospective cohort study. Clin Infect Dis (2013) 0.97
Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States. Mov Disord (2010) 0.97
Evaluation of the ESRD managed care demonstration operations. Health Care Financ Rev (2003) 0.96
Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitals. Am J Health Syst Pharm (2003) 0.95
Chiropractic users and nonusers: differences in use, attitudes, and willingness to use nonmedical doctors for primary care. J Manipulative Physiol Ther (2006) 0.93
Budget impact analysis of rapid screening for Staphylococcus aureus colonization among patients undergoing elective surgery in US hospitals . Infect Control Hosp Epidemiol (2008) 0.91
Patient selection in the ESRD managed care demonstration. Health Care Financ Rev (2003) 0.91
Quality of life and patient satisfaction: ESRD managed care demonstration. Health Care Financ Rev (2003) 0.90
Development and validation of a subjective post sleep diary (SPSD) to assess sleep status in subjects with restless legs syndrome. Sleep Med (2011) 0.90
New 4-aryl-1,4-dihydropyridines and 4-arylpyridines as P-glycoprotein inhibitors. Drug Metab Dispos (2004) 0.90
Costs and benefits of rapid screening of methicillin-resistant Staphylococcus aureus carriage in intensive care units: a prospective multicenter study. Crit Care (2012) 0.89
Intercenter reproducibility of binary typing for Staphylococcus aureus. J Microbiol Methods (2002) 0.89
Improving quinolone use in hospitals by using a bundle of interventions in an interrupted time series analysis. Antimicrob Agents Chemother (2010) 0.88
Fighting bacterial resistance at the root: need for adapted EMEA guidelines. Lancet Infect Dis (2011) 0.87
High Resolution Typing by Whole Genome Mapping Enables Discrimination of LA-MRSA (CC398) Strains and Identification of Transmission Events. PLoS One (2013) 0.87
Economic consequences of antimicrobial resistance. Surg Infect (Larchmt) (2002) 0.86
Survey of pharmacist collaborative drug therapy management in hospitals. Am J Health Syst Pharm (2006) 0.86
Costs of treating lower respiratory tract infections. Am J Manag Care (2008) 0.85
Selective decontamination of digestive tract in intensive care. Lancet (2003) 0.85
Is the perceived association between Chlamydia pneumoniae and vascular diseases biased by methodology? J Clin Microbiol (2004) 0.84
Implementation of a bundle of care to reduce surgical site infections in patients undergoing vascular surgery. PLoS One (2013) 0.84
Agreement among healthcare professionals in ten European countries in diagnosing case-vignettes of surgical-site infections. PLoS One (2013) 0.84
Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: results from two double-blind, multicenter, placebo-controlled clinical trials. BMC Neurol (2011) 0.84
Validation of a Women's Sexual Interest Diagnostic Interview--Short Form (WSID-SF) and a Daily Log of Sexual Activities (DLSA) in postmenopausal women with hypoactive sexual desire disorder. J Sex Med (2009) 0.83
Influence of extended-spectrum beta-lactams on gram-negative bacterial resistance. Am J Health Syst Pharm (2008) 0.83
ESRD managed care demonstration: financial implications. Health Care Financ Rev (2003) 0.83
Relationship of minimal inhibitory concentration and bactericidal activity to efficacy of antibiotics for treatment of ventilator-associated pneumonia. Semin Respir Crit Care Med (2006) 0.82
Resource utilisation, charges and mortality following hospital inpatient admission for congestive heart failure among the elderly in the US. J Med Econ (2008) 0.82
New diagnostic microarray (Check-KPC ESBL) for detection and identification of extended-spectrum beta-lactamases in highly resistant Enterobacteriaceae. J Clin Microbiol (2011) 0.82
Integron class 1 reservoir among highly resistant gram-negative microorganisms recovered at a Dutch teaching hospital. Infect Control Hosp Epidemiol (2009) 0.81
Whole-Genome Sequences of Staphylococcus aureus ST398 Strains of Animal Origin. Genome Announc (2013) 0.81
Fluctuations and randomness of movement of the bead powered by a single kinesin molecule in a force-clamped motility assay: Monte Carlo simulations. Biophys J (2002) 0.79
Evaluation of a commercial real-time PCR for the detection of extended spectrum β-lactamase genes. J Med Microbiol (2014) 0.79
Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study. Pharmacoeconomics (2009) 0.79
Clinical experience with linezolid in conjunction with wound coverage techniques for skin and soft-tissue infections and postoperative osteomyelitis. Ann Plast Surg (2004) 0.78
Trends in CNS prescribing following the economic slowdown. Psychiatry (Edgmont) (2009) 0.77
Control of MRSA in intensive care units. BMJ (2011) 0.77
Methicillin-resistant Staphylococcus aureus decolonization: "yes, we can," but will it help? Infect Control Hosp Epidemiol (2009) 0.77
Observations on vancomycin use in U.S. hospitals. Am J Health Syst Pharm (2007) 0.77
A description of clinical characteristics and treatment patterns observed within prescribed opioid users in Germany and the UK. Pain Manag (2014) 0.77
A comparison of cost and efficacy of three incontinence skin barrier products. Ostomy Wound Manage (2004) 0.77
Impact of serological methodology on assessment of the link between Chlamydia pneumoniae and vascular diseases. Clin Diagn Lab Immunol (2004) 0.77
[Questions and answers about MRSA in farm animals]. Tijdschr Diergeneeskd (2007) 0.76
Direct costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment with macrolide antibacterials in the US. Pharmacoeconomics (2007) 0.76
Extended-spectrum β-lactamase-producing Enterobacteriaceae in hospital food: a risk assessment. Infect Control Hosp Epidemiol (2014) 0.76
Glucose supply and insulin demand dynamics of antidiabetic agents. J Diabetes Sci Technol (2010) 0.76
Prolonged colonisation with Escherichia coli O25:ST131 versus other extended-spectrum beta-lactamase-producing E. coli in a long-term care facility with high endemic level of rectal colonisation, the Netherlands, 2013 to 2014. Euro Surveill (2016) 0.76